These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 1990838
1. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Bulman DE, Murphy EG, Zubrzycka-Gaarn EE, Worton RG, Ray PN. Am J Hum Genet; 1991 Feb; 48(2):295-304. PubMed ID: 1990838 [Abstract] [Full Text] [Related]
2. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Winnard AV, Klein CJ, Coovert DD, Prior T, Papp A, Snyder P, Bulman DE, Ray PN, McAndrew P, King W. Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493 [Abstract] [Full Text] [Related]
3. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot. Voit T, Stuettgen P, Cremer M, Goebel HH. Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822 [Abstract] [Full Text] [Related]
4. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. Arahata K, Beggs AH, Honda H, Ito S, Ishiura S, Tsukahara T, Ishiguro T, Eguchi C, Orimo S, Arikawa E. J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400 [Abstract] [Full Text] [Related]
5. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype? Vainzof M, Takata RI, Passos-Bueno MR, Pavanello RC, Zatz M. Hum Mol Genet; 1993 Jan; 2(1):39-42. PubMed ID: 8490621 [Abstract] [Full Text] [Related]
6. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence. Augier N, Boucraut J, Léger J, Anoal M, Nicholson LV, Voelkel MA, Léger JJ, Pellissier JF. J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523 [Abstract] [Full Text] [Related]
7. Prediction of dystrophin phenotype by DNA analysis in Duchenne/Becker muscular dystrophy. Specht LA, Beggs AH, Korf B, Kunkel LM, Shapiro F. Pediatr Neurol; 1992 Feb; 8(6):432-6. PubMed ID: 1476571 [Abstract] [Full Text] [Related]
8. Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases. Jay V, Becker LE, Ackerley C, Ray P. Pediatr Pathol; 1993 Feb; 13(5):635-57. PubMed ID: 8247961 [Abstract] [Full Text] [Related]
9. [Molecular genetics of Duchenne/Becker muscular dystrophy]. Saito K, Ikeya K, Kondo E, Yamauchi A, Komine S, Fukuyama Y. Nihon Rinsho; 1993 Sep; 51(9):2420-7. PubMed ID: 8411723 [Abstract] [Full Text] [Related]
10. [Detection of dystrophin with anti-peptide antibodies]. Takeda A, Jimi T, Misugi N, Miyake S, Kumagai T, Nakamura Y, Wakayama Y. Rinsho Byori; 1992 Sep; 40(9):953-8. PubMed ID: 1434031 [Abstract] [Full Text] [Related]
11. Dystrophin or a "related protein" in Duchenne muscular dystrophy? Nicholson LV, Johnson MA, Davison K, O'Donnell E, Falkous G, Barron M, Harris JB. Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480 [Abstract] [Full Text] [Related]
12. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy. Muntoni F, Mateddu A, Cianchetti C, Marrosu MG, Clerk A, Cau M, Congiu R, Cao A, Melis MA. J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):26-31. PubMed ID: 8429320 [Abstract] [Full Text] [Related]
13. Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec. Simard LR, Gingras F, Delvoye N, Vanasse M, Melançon SB, Labuda D. Hum Genet; 1992 Jun; 89(4):419-24. PubMed ID: 1618490 [Abstract] [Full Text] [Related]
14. Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Gangopadhyay SB, Sherratt TG, Heckmatt JZ, Dubowitz V, Miller G, Shokeir M, Ray PN, Strong PN, Worton RG. Am J Hum Genet; 1992 Sep; 51(3):562-70. PubMed ID: 1496988 [Abstract] [Full Text] [Related]
15. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. Mizuno Y, Nonaka I, Hirai S, Ozawa E. J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010 [Abstract] [Full Text] [Related]
16. Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia. Peterlin B, Zidar J, Meznaric-Petrusa M, Zupancic N. Clin Genet; 1997 Feb; 51(2):94-7. PubMed ID: 9111995 [Abstract] [Full Text] [Related]
17. Unraveling the mysteries of Duchenne and Becker muscular dystrophy. Hyser CL. Mol Chem Neuropathol; 1989 Feb; 10(1):15-20. PubMed ID: 2660836 [Abstract] [Full Text] [Related]
18. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Nicholson LV, Johnson MA, Gardner-Medwin D, Bhattacharya S, Harris JB. Acta Neuropathol; 1990 Feb; 80(3):239-50. PubMed ID: 2205076 [Abstract] [Full Text] [Related]
19. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Müller CR, Lindlöf M, Kaariainen H, de la Chapellet A, Kiuru A, Savontaus ML, Gilgenkrantz H, Récan D, Chelly J, Kaplan JC, Covone AE, Archidiacono N, Romeo G, Liechti-Gailati S, Schneider V, Braga S, Moser H, Darras BT, Murphy P, Francke U, Chen JD, Morgan G, Denton M, Greenberg CR, Wrogemann K, Blonden LA, van Paassen MB, van Ommen GJ, Kunkel LM. Am J Hum Genet; 1989 Oct; 45(4):498-506. PubMed ID: 2491009 [Abstract] [Full Text] [Related]
20. Amino-terminal deletion of 53% of dystrophin results in an intermediate Duchenne-Becker muscular dystrophy phenotype. Takeshima Y, Nishio H, Narita N, Wada H, Ishikawa Y, Ishikawa Y, Minami R, Nakamura H, Matsuo M. Neurology; 1994 Sep; 44(9):1648-51. PubMed ID: 7936290 [Abstract] [Full Text] [Related] Page: [Next] [New Search]